(3 Referenzen)-
- Target Alle Annexin V (ANXA5) Kits anzeigen
- Annexin V (ANXA5) (Annexin A5 (ANXA5))
- Konjugat
- FITC
- Applikation
- Flow Cytometry (FACS)
- Produktmerkmale
- ApoScreen® Annexin V Apoptosis Kit-FITC
- Top Product
- Discover our top product ANXA5 ELISA Kit
-
Annexin A5 (ANXA5) ELISA Kit
ANXA5 Reaktivität: Human Colorimetric Sandwich ELISA 31.2 pg/mL - 2000 pg/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reaktivität: Maus Colorimetric Sandwich ELISA 1.563 ng/mL - 100 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reaktivität: Ratte Colorimetric Sandwich ELISA 0.313 ng/mL - 20 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reaktivität: Human Colorimetric Sandwich ELISA 0.31 ng/mL - 20 ng/mL Cell Culture Supernatant, Plasma, Serum
Annexin A5 (ANXA5) ELISA KitANXA5 Reaktivität: Affe Colorimetric Sandwich ELISA 1.563 ng/mL - 100 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reaktivität: Huhn Colorimetric Sandwich ELISA 1.563 ng/mL - 100 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reaktivität: Pferd Colorimetric Sandwich ELISA 1.563 ng/mL - 100 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reaktivität: Ratte Colorimetric Sandwich ELISA 0.15 ng/mL - 10 ng/mL Plasma, Serum
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Handhabung
-
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed. - Lagerung
- 4 °C
-
-
: "Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death." in: Oncotarget, Vol. 6, Issue 33, pp. 34573-91, (2016) (PubMed).
: "8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers." in: Molecular cancer therapeutics, Vol. 11, Issue 11, pp. 2495-504, (2012) (PubMed).
: "Inhibition effect of siRNA-downregulated UHRF1 on breast cancer growth." in: Cancer biotherapy & radiopharmaceuticals, Vol. 26, Issue 2, pp. 183-9, (2011) (PubMed).
-
: "Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death." in: Oncotarget, Vol. 6, Issue 33, pp. 34573-91, (2016) (PubMed).
-
- Target
- Annexin V (ANXA5) (Annexin A5 (ANXA5))
- Andere Bezeichnung
- Annexin V (ANXA5 Produkte)
-
Sie sind hier:
